Home
> SARS-COV-2
SARS-COV-2
Europe establishing rehab centres for patients who recovered from COVID-19
Healthcare experts have reportedly observed breathing difficulties, fatigue, and brain fog in people who have survived the disease.
COVID-19 pool testing gets FDA approval to ease burden on resources and save time
The approach being proposed will collect samples from up to four individuals which are then mixed in one batch that will use up one testing kit only.
Coronavirus: N95 mask inventor comes out of retirement to help health workers
The way N95 masks work is via the special filter that can block up to 95 percent of airborne particles.
Oxford COVID-19 vaccine shows encouraging results; scientists calls for human trials
It was implied that the volunteers being eyed for the human challenge trials should be healthy individuals in their 20s.
SARS-CoV-2 vaccine early-stage human testing results are promising, top expert claims
The Moderna Inc vaccine candidate reportedly elicited the desired immune responses from volunteers and apparently has little to no side effects.
Health officials speculate around 40% of COVID-19 infections are asymptomatic
The number of asymptomatic subjects appears to have grown from the ones listed in April and May, which was 25 and 35 percent, respectively.
Study shows SARS-CoV-2 could possibly affect the heart and other major organs
The British Heart Foundation confirms that their findings suggest COVID-19 causes abnormal changes to the vital organ.
COVID-19 lockdowns: Psychiatrists caution against mental health issues among youth
It was noted that it is likely for youths to have fears about certain aspects of their future such as those related to finances and employment.
Debate continues among experts regarding SARS-CoV-2 transmission via aerosol
Although the WHO acknowledged the possibility that SARS-CoV-2 can be transmitted in aerosol, it requires definitive proof before it reviews safety protocols.
COVID-19 researchers eyeing tuberculosis vaccine in lowering death rates
It appears countries with more people inoculated with Bacille Calmette-Guarin (BCG) purportedly had lower death rates.
COVID-19 can trigger complicated grief among those who lost loved ones, experts warn
Among the symptoms observed were changes in sleeping patterns, poor appetite, low energy levels, guilt, sadness, and anger.
Novel coronavirus studies find alarming rise of neurological complications among adults
COVID-19 might be a contributing factor to the increasing cases of acute disseminated encephalomyelitis (ADEM) in adults.
New findings suggest silent transmissions likely responsible for COVID-19 outbreaks
The medical industry has been tirelessly working to understand everything there is to know about the pathogen.
COVID-19: Analysts still eyeing Bitcoin as inflation hedge despite perceived volatility
Even renowned hedge fund manager Paul Tudor Jones believes a bullish turnout is in the making for Bitcoin.
NHS coronavirus contact tracing app seems to be stuck in development limbo
Earlier this week, the House of Lords science committee had a discussion with NHS Improvement Conservative peer and chair Baroness Dido Harding.
COVID-19 vaccine: US awards $1.6bn 'Operation Warp Speed' funding to Novavax
In the past, Novavax has relied on the same model to manufacture vaccine candidates for respiratory syncytial, Ebola, and influenza viruses.
Johnson holds care home and hospital workers accountable for rising COVID-19 death toll
Majority of the care providers felt insulted given that they have gone beyond what was expected of them.
REGN-COV2: Upsurge of COVID-19 cases push Regeneron to rush clinical trials
Another parallel study will involve 1,850 patients that are hospitalised and 1,050 which are non-hospitalised.
Fourth of July celebrations to push US COVID-19 numbers up in coming weeks: Experts
Public health officials are worried that advisories were disregarded much like during the Memorial Day weekend a couple of months ago.
COVID-19: Researchers claim aerosol transmission risk was ignored by WHO
So far, data shows the number of deaths from COVID-19 has already surpassed half a million globally.
Fourth of July revellers need to be careful around fireworks after using hand sanitisers: CDC
In order to be effective against SARS-CoV-2, the CDC recommends hand sanitisers with at least 60 percent alcohol, which is highly flammable.
Upsurge of COVID-19 cases prompt social media platforms to issue more reminders
Bill Gates recently criticised social media companies for their failure to address misinformation about the 2019 novel coronavirus
Scientists considering human challenge trials for testing SARS-CoV-2 vaccine
Despite the risks involved, it appears that there are folks who are surprisingly willing to participate in this procedure.
Twitter CEO makes substantial donation for COVID-19 relief to Sean Penn's CORE
CORE is a non-profit organisation founded by renowned actor Sean Penn that provides assistance during disasters.
The Pulse pendant might be NASA's innovative solution to reduce COVID-19 transmissions
To make it even more accessible for those who want it, the project will require a 3D printer, a small motor, wiring, and other materials.
Rapidly growing number of virus-focused labs could lead to inaccurate reporting: Experts
The IBMS suggest that officials should focus on the existing labs first in order to resolve the issues involved with the submission of patient data.
Gilead Sciences announces pricing for remdesivir after conditional approval
Results from studies show that remdesivir can shorten the recovery period from 15 to 11 days, which can help healthcare facilities cater to more patients.
Repurposing certain drugs might lead to COVID-19, claims immunologist
At 35 years old, Dr. David Fajgenbaum now heads the Cytokine Storm Treatment & Laboratory of the University of Pennsylvania Perelman School of Medicine.
COVID-19: Experts caution against dental visits unless specialists says so
Due to the highly contagious nature of the 2019 novel coronavirus, many are afraid to even see their doctors.
Imperial College COVID-19 vaccine trial: First volunteer receives experimental inoculation
Once it has been administered, the vaccine then triggers an action wherein the body's cells attempt to recreate a copy of the virus' spike protein.